SCHEMBL7742102

SCHEMBL7742102

Cc1c(NN2C=NCC2)ccc2cccnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 5/20 0.39
LMNA P02545 4/20 0.39
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
MMP2 P08253 3/20 0.39
ALOX15 P16050 2/20 0.39
GMNN O75496 1/20 0.39
TP53 P04637 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MMP9 P14780 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8690223 0.99 MAPT (0.38) MAPTKDM4EHTTLMNACCR1
Hydrochloric Acid SCHEMBL27429683 0.99 MAPT (0.38) MAPTKDM4EHTTLMNACCR1
Hydrochloric Acid SCHEMBL27424280 0.83 CYP1A2 (0.35) MAPTKDM4EHTTLMNASMN1; SMN2
SCHEMBL7742104 0.78 KDM4E (0.37) MAPTKDM4EHTTLMNATDP1
SCHEMBL8117248 0.77 L3MBTL1 (0.41) MAPTKDM4EHTTLMNACCR1
Hydrochloric Acid SCHEMBL8690527 0.77 KDM4E (0.36) MAPTKDM4EHTTLMNATDP1
Hydrochloric Acid SCHEMBL27402631 0.77 KDM4E (0.36) MAPTKDM4EHTTLMNATDP1
Hydrochloric Acid SCHEMBL8111472 0.76 L3MBTL1 (0.40) MAPTKDM4EHTTLMNACCR1
SCHEMBL7743450 0.75 LRRK2 (0.36) MAPTHSP90AA1L3MBTL1ALDH1A1SLC40A1
SCHEMBL7202843 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423724-B1 PREVENTION, THERAPY DISEASE THE PROCTER & GAMBLE COMPANY 2002-07-23 US disclosed
CN-1085945-C 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2002-06-05 CN disclosed
US-5916900-A TREATMENT OF NASAL CONGESTION, ASTHMA, COUGH, CARDIOVASCULAR DISORDERS, OCULAR DISORDERS, GASTROINTESTINAL DISORDERS, MIGRAINES, SUSBSTANCE ABUSE THE PROCTER & GAMBLE COMPANY (US) 1999-06-29 US disclosed
US-5716966-A RESPIRATORY SYSTEM DISORDERS; VISION DEFECTS; GASTROINTESTINAL DISORDERS THE PROCTER & GAMBLE COMPANY (US) 1998-02-10 US disclosed
CN-1137754-A 7-(2-imidazolinylamino) quinoline compounds as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 1996-12-11 CN disclosed
US-5576437-A 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 1996-11-19 US disclosed
EP-0734261-A1 7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1996-10-02 EP disclosed
WO-1995020386-A1 7-(2-IMIDAZOLINYLAMINO)QUINOLINE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1995-08-03 WO disclosed